• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 – 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o NPWT devices – Market size and forecast 2019-2024
o HBOT devices – Market size and forecast 2019-2024
o Others – Market size and forecast 2019-2024
o Market opportunity by Product
• Customer landscape
o Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America – Market size and forecast 2019-2024
o Europe – Market size and forecast 2019-2024
o APAC – Market size and forecast 2019-2024
o ROW – Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Competitive scenario
o Vendor landscape
o Landscape disruption
o Industry risks
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o 3M Co.
o Cardinal Health Inc.
o ConvaTec Group Plc
o Genadyne Biotechnologies Inc.
o H&R Healthcare
o Lohmann & Rauscher GmbH & Co. KG
o Medela AG
o Molnlycke Health Care AB
o Paul Hartmann AG
o Smith & Nephew Plc
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Parent market
• 9: Market characteristics
• 10: Offerings of vendors included in the market definition
• 11: Market segments
• 12: Global – Market size and forecast 2019 – 2024 ($ million)
• 13: Global market: Year-over-year growth 2019 – 2024 (%)
• 14: Five forces analysis 2019 & 2024
• 15: Bargaining power of buyers
• 16: Bargaining power of suppliers
• 17: Threat of new entrants
• 18: Threat of substitutes
• 19: Threat of rivalry
• 20: Market condition – Five forces 2019
• 21: Product – Market share 2019-2024 (%)
• 22: Comparison by Product
• 23: NPWT devices – Market size and forecast 2019-2024 ($ million)
• 24: NPWT devices – Year-over-year growth 2019-2024 (%)
• 25: HBOT devices – Market size and forecast 2019-2024 ($ million)
• 26: HBOT devices – Year-over-year growth 2019-2024 (%)
• 27: Others – Market size and forecast 2019-2024 ($ million)
• 28: Others – Year-over-year growth 2019-2024 (%)
• 29: Market opportunity by Product
• 30: Customer landscape
• 31: Market share by geography 2019-2024 (%)
• 32: Geographic comparison
• 33: North America – Market size and forecast 2019-2024 ($ million)
• 34: North America – Year-over-year growth 2019-2024 (%)
• 35: Europe – Market size and forecast 2019-2024 ($ million)
• 36: Europe – Year-over-year growth 2019-2024 (%)
• 37: APAC – Market size and forecast 2019-2024 ($ million)
• 38: APAC – Year-over-year growth 2019-2024 (%)
• 39: ROW – Market size and forecast 2019-2024 ($ million)
• 40: ROW – Year-over-year growth 2019-2024 (%)
• 41: Key leading countries
• 42: Market opportunity by geography ($ million)
• 43: Impact of drivers and challenges
• 44: Vendor landscape
• 45: Landscape disruption
• 46: Industry risks
• 47: Vendors covered
• 48: Market positioning of vendors
• 49: 3M Co. – Overview
• 50: 3M Co. – Business segments
• 51: 3M Co. – Key offerings
• 52: 3M Co. – Key customers
• 53: 3M Co. – Segment focus
• 54: Cardinal Health Inc. – Overview
• 55: Cardinal Health Inc. – Business segments
• 56: Cardinal Health Inc. – Key offerings
• 57: Cardinal Health Inc. – Key customers
• 58: Cardinal Health Inc. – Segment focus
• 59: ConvaTec Group Plc – Overview
• 60: ConvaTec Group Plc – Business segments
• 61: ConvaTec Group Plc – Key offerings
• 62: ConvaTec Group Plc – Key customers
• 63: ConvaTec Group Plc – Segment focus
• 64: Genadyne Biotechnologies Inc. – Overview
• 65: Genadyne Biotechnologies Inc. – Product and service
• 66: Genadyne Biotechnologies Inc. – Key offerings
• 67: Genadyne Biotechnologies Inc. – Key customers
• 68: Genadyne Biotechnologies Inc. – Segment focus
• 69: H&R Healthcare – Overview
• 70: H&R Healthcare – Product and service
• 71: H&R Healthcare – Key offerings
• 72: H&R Healthcare – Key customers
• 73: H&R Healthcare – Segment focus
• 74: Lohmann & Rauscher GmbH & Co. KG – Overview
• 75: Lohmann & Rauscher GmbH & Co. KG – Product and service
• 76: Lohmann & Rauscher GmbH & Co. KG – Key offerings
• 77: Lohmann & Rauscher GmbH & Co. KG – Key customers
• 78: Lohmann & Rauscher GmbH & Co. KG – Segment focus
• 79: Medela AG – Overview
• 80: Medela AG – Product and service
• 81: Medela AG – Key offerings
• 82: Medela AG – Key customers
• 83: Medela AG – Segment focus
• 84: Molnlycke Health Care AB – Overview
• 85: Molnlycke Health Care AB – Product and service
• 86: Molnlycke Health Care AB – Key offerings
• 87: Molnlycke Health Care AB – Key customers
• 88: Molnlycke Health Care AB – Segment focus
• 89: Paul Hartmann AG – Overview
• 90: Paul Hartmann AG – Business segments
• 91: Paul Hartmann AG – Key offerings
• 92: Paul Hartmann AG – Key customers
• 93: Paul Hartmann AG – Segment focus
• 94: Smith & Nephew Plc – Overview
• 95: Smith & Nephew Plc – Business segments
• 96: Smith & Nephew Plc – Key offerings
• 97: Smith & Nephew Plc – Key customers
• 98: Smith & Nephew Plc – Segment focus
• 99: Currency conversion rates for US$
• 100: Research Methodology
• 101: Validation techniques employed for market sizing
• 102: Information sources
• 103: List of abbreviations
【掲載企業】
3M Co., Cardinal Health Inc., ConvaTec Group Plc, Genadyne Biotechnologies Inc., H&R Healthcare, Lohmann & Rauscher GmbH & Co. KG, Medela AG, Molnlycke Health Care AB, Paul Hartmann AG, Smith & Nephew Plc